Today: 21 May 2026
Browse Category

NASDAQ:QBTS 12 January 2026 - 12 May 2026

D-Wave’s Bookings Spike Keeps QBTS in Play, but the Revenue Math Still Has to Catch Up

D-Wave’s Bookings Spike Keeps QBTS in Play, but the Revenue Math Still Has to Catch Up

D-Wave reported first-quarter bookings of $33.4 million, up nearly 2,000% from a year earlier, driven by a $20 million system sale to Florida Atlantic University. Revenue dropped 81% to $2.9 million, and net loss widened to $18.4 million. QBTS shares closed Monday up 6.47% at $24.03. Operating expenses more than doubled to $56.5 million, partly due to the Quantum Circuits acquisition.
D-Wave Quantum Stock Faces a Big Earnings Test After 55% Rally

D-Wave Quantum Stock Faces a Big Earnings Test After 55% Rally

D-Wave Quantum will report first-quarter results before markets open Tuesday, with consensus revenue estimates around $4.14 million, sharply below last year’s $15 million. Shares rose 6.5% to $24.03 Monday and traded higher after hours. The company disclosed $32.8 million in bookings as of Feb. 25, including a $20 million sale to Florida Atlantic University. Analyst John McPeake maintained a Buy rating and $43 target ahead of the report.
D-Wave Quantum Stock Slides Before Q1 Earnings as Investors Look for Proof Behind the Rally

D-Wave Quantum Stock Slides Before Q1 Earnings as Investors Look for Proof Behind the Rally

D-Wave Quantum shares fell 4.3% to $18.49 Friday ahead of its May 12 first-quarter earnings report. The company previously reported $32.8 million in early-2026 bookings, surpassing its full-year 2025 total. CEO Alan Baratz and CFO John Markovich will discuss results and outlook on a call at 8 a.m. ET. Analyst Nehal Chokshi rated D-Wave Market Perform with a $22 target.
D-Wave Quantum Stock Jumps Again as Nvidia Ising Launch and CEO Pitch Put QBTS Back in Focus

D-Wave Quantum Stock Jumps Again as Nvidia Ising Launch and CEO Pitch Put QBTS Back in Focus

D-Wave Quantum shares rose about 8% in premarket trading Wednesday after a 15.8% jump Tuesday, following Nvidia’s release of open-source quantum AI models. CEO Alan Baratz promoted D-Wave as a commercial quantum player at Washington events, while a new bearish note warned the stock trades ahead of fundamentals. IonQ and Rigetti also surged Tuesday. D-Wave reported 2025 revenue of $24.6 million and recent bookings over $32.8 million.
D-Wave Quantum stock rises on earnings as bookings surge; what QBTS traders watch next

D-Wave Quantum stock rises on earnings as bookings surge; what QBTS traders watch next

D-Wave Quantum Inc shares closed up 2.4% at $20.13, rising further after hours as the company reported 2025 results and strong 2026 bookings of over $32.8 million through Feb. 25. Fourth-quarter revenue reached $2.75 million, with a net loss of $42.33 million. Cash and marketable securities totaled $884.5 million. Quantum peers IonQ, Rigetti, and Quantum Computing Inc also gained.
D-Wave Quantum (QBTS) stock drops after hours as quantum shares wobble — what to watch next

D-Wave Quantum (QBTS) stock drops after hours as quantum shares wobble — what to watch next

D-Wave Quantum shares fell 7.4% to $23.75 in after-hours trading Monday, erasing earlier gains above $26. Other quantum-computing stocks, including IonQ and Rigetti, also dropped sharply. The declines came ahead of D-Wave’s Qubits conference in Florida this week, where investors expect updates on its product roadmap and customer progress. IonQ announced a $1.8 billion deal to acquire SkyWater Technology.
D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

D-Wave Quantum Inc shares fell 5.4% to $25.94 early Friday after a prospectus registered the resale of over 10.4 million shares linked to its Quantum Circuits acquisition. Trading volume topped 23 million shares. D-Wave closed the Quantum Circuits deal this week, adding gate-model technology to its offerings. Venture investors including Sequoia and ARCH are among those eligible to sell shares.
D-Wave QBTS stock sinks as 10.4 million-share resale filing shadows Quantum Circuits deal

D-Wave QBTS stock sinks as 10.4 million-share resale filing shadows Quantum Circuits deal

D-Wave Quantum shares dropped 6.6% to $25.25 after an SEC filing showed a potential resale of over 10.4 million shares tied to its Quantum Circuits acquisition. The company closed the $250 million cash-and-stock deal on Jan. 20. Other quantum stocks, including IonQ and Rigetti, also fell sharply. Investors await updates at D-Wave’s Qubits 2026 event next week.
D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal

D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal

D-Wave shares rose 0.5% to $27.17 Wednesday after completing its Quantum Circuits acquisition. A new filing allows former Quantum Circuits holders to sell up to 10.43 million D-Wave shares, with no proceeds going to D-Wave. Investors are watching for selling pressure and product updates at next week’s Qubits conference.
IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week

IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week

IonQ rose 6.8% to $50.80 Friday, Rigetti gained 3.7%, and Quantum Computing Inc added 4.0% after Rosenblatt Securities initiated Buy ratings on Rigetti and QUBT. Rigetti delayed its 108-qubit system launch to late Q1 2026. Quantum Computing Inc was named stalking horse bidder for $22 million in Luminar assets. D-Wave Quantum edged up 0.5%.
D-Wave Quantum (QBTS) stock closes higher as insider sales filings surface ahead of holiday week

D-Wave Quantum (QBTS) stock closes higher as insider sales filings surface ahead of holiday week

D-Wave Quantum (QBTS) rose 0.5% to $28.83 Friday on heavy volume, as insider filings showed CEO Alan Baratz and other executives sold shares, mostly to cover tax withholding. The company is working to close a $550 million deal for Quantum Circuits, with terms tied to share price and an April 6 deadline. U.S. markets are closed Monday for Martin Luther King Jr. Day.
D-Wave Quantum stock price rises after insider filings; QBTS traders eye Qubits 2026 next

D-Wave Quantum stock price rises after insider filings; QBTS traders eye Qubits 2026 next

D-Wave Quantum Inc shares rose 1.1% to $29.03 Friday after CEO Alan Baratz and CFO John Markovich disclosed tax-related “sell-to-cover” stock sales in SEC filings. The company’s $550 million Quantum Circuits acquisition remains pending antitrust approval. Trading volume reached about 34 million shares. Investors await D-Wave’s Qubits 2026 event set for Jan. 27–28.
D-Wave Quantum (QBTS) stock slips after-hours on insider filings — what investors watch next

D-Wave Quantum (QBTS) stock slips after-hours on insider filings — what investors watch next

D-Wave Quantum shares dropped 4.7% to $28.72 in after-hours trading after SEC filings showed stock sales by CEO Alan Baratz, CFO John Markovich, and legal chief Diane Nguyen, some tied to tax withholding or preset plans. The company recently agreed to buy Quantum Circuits for $550 million in cash and stock. Traders are watching the deal timeline and the upcoming Qubits 2026 conference.
Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

D-Wave Quantum shares fell 0.5% to $29.99 Thursday afternoon, reversing gains from the previous session. Honeywell said Quantinuum plans to file a confidential S-1 for a potential IPO. D-Wave’s $550 million Quantum Circuits acquisition is expected to close by late January. Trading volume for D-Wave reached about 32 million shares.
D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave Quantum shares rose 4.7% to $30.15 in after-hours trading Wednesday after Honeywell said its Quantinuum unit plans to file confidential IPO documents with the SEC. Other U.S. quantum stocks, including IonQ and Rigetti, also gained. D-Wave’s $550 million acquisition of Quantum Circuits is expected to close by late January, pending approvals. Traders are watching for D-Wave’s upcoming user conference and the Quantum Circuits deal.
1 2 3 4

Stock Market Today

  • Australia Shares Rise on U.S.-Iran Peace Deal Hopes; Jobs Data Awaited
    May 20, 2026, 9:49 PM EDT. Australia's S&P/ASX 200 index climbed on Thursday, buoyed by optimism over a potential U.S.-Iran peace deal. Most sectors closed higher amid easing geopolitical tensions. Investors are now focusing on upcoming local jobs data, which is expected to provide insight into Australia's economic health. The market reacted to fresh diplomatic developments, reflecting increased risk appetite among traders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop